However, in animal models of T1DM, systemic fenofibrate treatment has a protective effect on the blood-retina barrier and protects against neovascularization in the oxygen-induced retinopathy model, notably by attenuating the overexpression of VEGF, CCL2, and ICAM-1 (39). Here, VEGFA is linked to retinal disorder.